Evidence map›Paper›PMID 37999530›Full record

ArticleToxics2023

Cognitive Performance and Exposure to Organophosphate Flame Retardants in Children: Evidence from a Cross-Sectional Analysis of Two European Mother-Child Cohorts.

Valentina Rosolen, Elisa Giordani, Marika Mariuz, Maria Parpinel, Vicente Mustieles, Liese Gilles, Eva Govarts, Laura Rodriguez Martin, Kirsten Baken, Greet Schoeters and 12 more

Open access · goldAbstract read
In one paragraph

Article in Toxics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 12 institutions in 8 countries.

Valentina RosolenCentral Directorate for Health, Social Policies and Disability, Friuli Venezia Giulia Region, Via Cassa Di Risparmio 10, 34121 Trieste, Italy.ORCID 0000-0003-1292-5564
Elisa GiordaniDepartment of Medicine, University of Udine, Via Colugna 50, 33100 Udine, Italy.ORCID 0000-0002-3599-9462
Marika MariuzDepartment of Medicine, University of Udine, Via Colugna 50, 33100 Udine, Italy.
Maria ParpinelDepartment of Medicine, University of Udine, Via Colugna 50, 33100 Udine, Italy.ORCID 0000-0003-1309-4467
Vicente MustielesCenter for Biomedical Research, University of Granada, 18012 Granada, Spain.ORCID 0000-0002-2010-5438
Liese GillesVITO Health, Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium.ORCID 0000-0002-3016-9750
Eva GovartsVITO Health, Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium.ORCID 0000-0002-6075-4862
Laura Rodriguez MartinVITO Health, Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium.
Kirsten BakenBrabantAdvies, Brabantlaan 3, 5216 TV 's-Hertogenbosch, The Netherlands.
Greet SchoetersDepartment of Biomedical Sciences & Toxicological Centre, University of Antwerp-Campus Drie Eiken, Universiteitsplein 1, Wilrijk, 2610 Antwerp, Belgium.ORCID 0000-0002-6556-4814
Ovnair SepaiToxicology Department, Science Group, UK Health Security Agency, Harwell Science and Innovation Campus, Didcot OX11 0RQ, UK.
Eva SovcikovaDepartment of Environmental Medicine, Faculty of Public Health, Slovak Medical University, 83303 Bratislava, Slovakia.
Lucia FabelovaDepartment of Environmental Medicine, Faculty of Public Health, Slovak Medical University, 83303 Bratislava, Slovakia.ORCID 0000-0002-6633-9096
Jiři KohoutekRECETOX, Faculty of Science, Masaryk University, Kotlářská 2, 611 37 Brno, Czech Republic.
Tina Kold JensenDepartment of Clinical Pharmacology, Pharmacy and Environmental Medicine, Institute of Public Health, University of Southern Denmark, 5000 Odense, Denmark.
Adrian CovaciToxicological Centre, University of Antwerp, Wilrijk, 2610 Antwerp, Belgium.ORCID 0000-0003-0527-1136
Maarten RoggemanToxicological Centre, University of Antwerp, Wilrijk, 2610 Antwerp, Belgium.
Lisa MelymukRECETOX, Faculty of Science, Masaryk University, Kotlářská 2, 611 37 Brno, Czech Republic.ORCID 0000-0001-6042-7688
Jana KlánováRECETOX, Faculty of Science, Masaryk University, Kotlářská 2, 611 37 Brno, Czech Republic.
Argelia CastanoNational Centre for Environmental Health, Instituto de Salud Carlos III, 28220 Majadahonda, Spain.ORCID 0000-0003-4152-7119
Marta Esteban LópezNational Centre for Environmental Health, Instituto de Salud Carlos III, 28220 Majadahonda, Spain.ORCID 0000-0002-4527-350X
Fabio BarboneDepartment of Medicine, Surgery and Health Sciences, University of Trieste, Strada di Fiume, 447, 34149 Trieste, Italy.
Flemish Institute for Technological Research · BEMasaryk University · CZUniversity of Antwerp · BEUniversity of Udine · ITInstituto de Salud Carlos III · ESSlovak Medical University · SKRegione Autonoma Friuli Venezia Giulia · ITTolbrug Specialistische Revalidatie · NLUK Health Security Agency · GBUniversidad de Granada · ESUniversity of Southern Denmark · DKUniversity of Trieste · IT

Funding

European Union 733032Health Insurance Denmark 2021-0173Ministry of Health of the Slovak Republic 2014/47-SZU-11Novo Nordisk Foundation, Denmark NNF17OC0029404Novo Nordisk Foundation, Denmark NNF19OC0058266Slovak Research and Development Agency APVV-0571-12The Danish Research Council 4004-00352B_FSS
6 · The paper itself

Abstract

The knowledge of the effects of organophosphate flame retardants on children's neurodevelopment is limited. The purpose of the present research is to evaluate the association between exposure to organophosphate flame retardants and children's neurodevelopment in two European cohorts involved in the Human Biomonitoring Initiative Aligned Studies. The participants were school-aged children belonging to the Odense Child Cohort (Denmark) and the PCB cohort (Slovakia). In each cohort, the children's neurodevelopment was assessed through the Full-Scale Intelligence Quotient score of the Wechsler Intelligence Scale for Children, using two different editions. The children's urine samples, collected at one point in time, were analyzed for several metabolites of organophosphate flame retardants. The association between neurodevelopment and each organophosphate flame retardant metabolite was explored by applying separate multiple linear regressions based on the approach of MM-estimation in each cohort. In the Danish cohort, the mean ± standard deviation for the neurodevelopment score was 98 ± 12; the geometric mean (95% confidence interval (95% CI)) of bis(1,3-dichloro-2-propyl) phosphate (BDCIPP) standardized by creatinine (crt) was 0.52 µg/g crt (95% CI = 0.49; 0.60), while that of diphenyl phosphate (DPHP) standardized by crt was 1.44 µg/g crt (95% CI = 1.31; 1.58). The neurodevelopment score showed a small, negative, statistically imprecise trend with BDCIPP standardized by crt (

Indexed as

childrenHBM4EU Aligned Studieshuman biomonitoringneurodevelopmentorganophosphate flame retardantsWISC

Identifiers

PMID37999530
PMCPMC10675051
OpenAlexW4387902701

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.